✦ LIBER ✦

9097 POSTER Effect of Somatostatin Analogs in the Control of Tumour Growth in Patients With Metastatic Lung Carcinoid Tumours

✍ Scribed by Fekih, M.; Baudin, E.; Ducreux, M.; Chougnet, C.; Leboulleux, S.; Duvillard, P.; Deandreis, D.; Dromain, C.; Schlumberger, M.; Guigay, J.

Book ID: 122001072
Publisher: Elsevier Science
Year: 2011
Tongue: English
Weight: 44 KB
Volume: 47
Category: Article
ISSN: 0959-8049
DOI: 10.1016/S0959-8049(11)72409-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Anti–Ri antibodies and limbic encephalit

Anti–Ri antibodies and limbic encephalitis in a patient with carcinoid tumour of the lung

✍ A. Harloff; S. Hummel; M. Kleinschmidt; S. Rauer 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 117 KB

6572 POSTER Effect of Everolimus + Octre

6572 POSTER Effect of Everolimus + Octreotide LAR in Patients With Advanced Lung Neuroendocrine Tumours – Analysis From RADIANT-2

✍ Fazio, N.; Granberg, D.; Grossman, A.; Saletan, S.; Winkler, R.E.; Panneerselvam 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 43 KB

EFFECT OF SOMATOSTATIN ON ABNORMAL GROWT

EFFECT OF SOMATOSTATIN ON ABNORMAL GROWTH HORMONE AND PROLACTIN SECRETION IN PATIENTS WITH THE CARCINOID SYNDROME

✍ A. GOMEZ-PAN; M. F. SCANLON; M. O. THORNER; L. H. REES; A. V. SCHALLY; R. HALL; 📂 Article 📅 1979 🏛 John Wiley and Sons 🌐 English ⚖ 387 KB

Randomized clinical trial of the effect

Randomized clinical trial of the effect of interferon α on survival in patients with disseminated midgut carcinoid tumours

✍ L. Kölby; G. Persson; S. Franzén; B. Ahrén 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 115 KB 👁 2 views

9018 POSTER DISCUSSION Identification of

9018 POSTER DISCUSSION Identification of Driver Mutations in Tumour Specimens From 1000 Patients With Lung Adenocarcinoma for the Lung Cancer Mutation Consortium (LCMC)

✍ Johnson, B.E.; Kris, M.G.; Kwiatkowski, D.J.; Wistuba, I.I.; Engelman, J.A.; Pao 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 43 KB

6571 POSTER Impact of Prior Somatostatin

6571 POSTER Impact of Prior Somatostatin Analog (SSA) Use on PFS in the Multicenter, Phase III Trial of Everolimus + Octreotide LAR Vs Placebo + Octreotide LAR in Patients With Advanced Neuroendocrine Tumours (RADIANT-2)

✍ Pavel, M.; Singh, N.; Passos, V.; Oberg, K. 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 61 KB